Tyche Industries Falls to 52-Week Low of Rs.111.1 Amidst Prolonged Downtrend

8 hours ago
share
Share Via
Tyche Industries, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.111.1, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock’s subdued performance over the past year, contrasting sharply with broader market trends.



Stock Price Movement and Market Context


On 8 December 2025, Tyche Industries recorded its lowest price in the last 52 weeks at Rs.111.1. Despite this, the stock marginally outperformed its sector by 0.56% on the day, though it remains below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This persistent trading below these technical benchmarks signals sustained downward momentum.


In comparison, the Sensex opened flat but later declined by 228.33 points, closing at 85,396.51, down 0.37%. The benchmark index remains close to its 52-week high of 86,159.02, trading above its 50-day and 200-day moving averages, indicating a generally bullish market environment contrasting with Tyche Industries’ performance.



Long-Term Price and Performance Analysis


Tyche Industries’ 52-week high was Rs.217, highlighting a stark contrast to the current low. Over the past year, the stock has generated a return of -45.58%, significantly underperforming the Sensex, which posted a positive return of 4.49% during the same period. This divergence underscores the challenges faced by the company relative to the broader market.


Further, the stock’s performance over the last three years and recent months has also lagged behind the BSE500 index, reflecting a consistent pattern of underperformance in both short and long-term horizons.




Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!



  • - Recent Momentum qualifier

  • - Stellar technical indicators

  • - Large Cap fast mover


Strike Now - View Stock →




Financial Performance and Profitability Trends


Tyche Industries’ financial data over recent years reveals a challenging environment. Net sales have shown a compound annual decline of 4.77% over the last five years, while operating profit has contracted at an annual rate of 27.59% during the same period. These figures indicate a subdued growth trajectory for the company.


In the latest six months, net sales stood at Rs.26.86 crores, reflecting a decline of 25.51% compared to previous periods. Profit after tax (PAT) for the same timeframe was Rs.3.95 crores, showing a contraction of 45.45%. Additionally, profit before tax excluding other income (PBT less OI) for the latest quarter was negative at Rs.-0.60 crores, representing a fall of 125.6% relative to the average of the preceding four quarters.



Valuation and Return Metrics


The company’s return on equity (ROE) is recorded at 6.8%, while the price-to-book value ratio stands at 0.8. This valuation places Tyche Industries at a premium relative to its peers’ historical averages, despite the subdued profitability and declining returns. Over the past year, profits have fallen by 29.4%, further highlighting the financial pressures faced by the company.



Debt and Shareholding Structure


Tyche Industries maintains a low average debt-to-equity ratio of zero, indicating minimal reliance on external borrowings. The majority shareholding is held by promoters, which suggests a concentrated ownership structure.




Why settle for Tyche Industries ? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!



  • - Comprehensive evaluation done

  • - Superior opportunities identified

  • - Smart switching enabled


Discover Superior Stocks →




Summary of Current Market Position


Tyche Industries’ stock price touching Rs.111.1 marks a significant low point within the last year, reflecting a continuation of its subdued financial and market performance. The stock remains below all major moving averages, signalling persistent downward pressure. This contrasts with the broader market, where the Sensex remains near its 52-week high and trades above key moving averages.


Financial indicators over recent quarters and years show contraction in sales and profits, alongside a valuation that remains elevated relative to peers. The company’s low debt level and promoter majority ownership are notable features amid this environment.


While the stock’s recent price action and financial data highlight ongoing challenges, these facts provide a clear picture of Tyche Industries’ current standing within the Pharmaceuticals & Biotechnology sector.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News